abstract |
The present invention relates to a composition for the prevention or treatment of cancer comprising the cambium- or procambium-derived cell line, its lysate, its extract or its culture as an active ingredient. The cell line, its lysate, its extract or its culture according to the present invention is safe for the human body by minimizing the side effects of existing drug treatments, but is directly involved in the growth of cancer, induces cancer cell death, and inhibits neovascularization that occurs when cancer occurs. Because it shows anti-cancer activity, it is useful for the prevention, treatment and symptom relief of cancer. |